Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 43, Issue 10 (Oct 2005)

Issues

Anti-N-homocysteinylated protein autoantibodies and cardiovascular disease

Hieronim Jakubowski
  • Department of Microbiology and Molecular Genetics, UMDNJ-New Jersey Medical School, International Center for Public Health, Newark, NJ, USA and Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznań, Poland
  • Other articles by this author:
  • De Gruyter OnlineGoogle Scholar
Published Online: 2005-09-30 | DOI: https://doi.org/10.1515/CCLM.2005.177

Abstract

Metabolic conversion of homocysteine (Hcy) to a chemically reactive metabolite, Hcy-thiolactone, catalyzed by methionyl-tRNA synthetase is the first step in a pathway that is suggested to contribute to Hcy toxicity in humans. The accumulation of Hcy-thiolactone is detrimental because of its intrinsic ability to modify proteins by forming N-Hcy-protein adducts, in which a carboxyl group of Hcy is N-linked to the ε-amino group of a protein lysine residue. N-linked Hcy occurs in each protein examined and constitutes a significant pool of Hcy in the blood. N-Hcy proteins are likely to be recognized as neo-self antigens and induce an autoimmune response. Indeed, we found that autoantibodies specific for an -Hcy-Lys epitope on N-Hcy-proteins occur in humans. Serum levels of anti-N-Hcy-protein autoantibodies are directly correlated with plasma tHcy, but not with plasma cysteine or methionine levels. In a group of male patients with stroke, levels of anti-N-Hcy-protein autoantibodies and tHcy were significantly higher than in a group of healthy subjects. In a group of male patients with angiographically documented coronary artery disease, seropositivity for anti-N-Hcy-protein autoantibodies occurred five-fold more frequently than in controls and was an independent predictor of coronary artery disease. These findings show that the formation of N-Hcy-proteins has important physiological consequences and support a hypothesis that N-Hcy-protein is a neo-self antigen that contributes to immune activation, an important modulator of atherogenesis.

Keywords: atherosclerosis; homocysteine-thiolactone; N-homocysteine-protein autoantibodies

References

  • 1.

    Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. J Am Med Assoc 2002;288:2015–22.Google Scholar

  • 2.

    Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 2002; 325:1202–6.Google Scholar

  • 3.

    Jakubowski H. Biochemical basis of homocysteine toxicity in humans. Mol Cell Life Sci 2004; 61:470–87.Google Scholar

  • 4.

    Lawrence de Konig AB, Werstuck GH, Zhou J, Austin RC. Hyperhomocysteinemia and its role in the development of atherosclerosis. Clin Biochem 2003; 36:431–41.Google Scholar

  • 5.

    Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem 2004; 50:3–32.CrossrefGoogle Scholar

  • 6.

    Jakubowski H. The determination of homocysteine-thiolactone in biological samples. Anal Biochem 2002; 308:112–9.Google Scholar

  • 7.

    Chwatko G, Jakubowski H. The determination of homocysteine-thiolactone in human plasma. Anal Biochem 2005; 337:271–7.Google Scholar

  • 8.

    Chwatko G, Jakubowski H. Urinary excretion of homocysteine-thiolactone in humans. Clin Chem 2005; 52:408–15.Google Scholar

  • 9.

    Jakubowski H. Translational accuracy of aminoacyl-tRNA synthetases: implications for atherosclerosis. J Nutr 2001; 131(Suppl):2983–7.Google Scholar

  • 10.

    Jakubowski H. Homocysteine is a protein amino acid in humans: implications for homocysteine-linked disease. J Biol Chem 2002; 277:30425–8.Google Scholar

  • 11.

    Glowacki R, Jakubowski H. Cross-talk between Cys-34 and lysine residues in human serum albumin revealed by N-homocysteinylation. J Biol Chem 2004; 279:10864–71.Google Scholar

  • 12.

    Jakubowski H. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999; 13:2277–83.Google Scholar

  • 13.

    Chambers JC, Obeid OA, Kooner JS. Physiological increments in plasma homocysteine induce vascular dysfunction in normal human subjects. Atheroscl Thromb Vasc Biol 1999; 19:2922–7.Google Scholar

  • 14.

    Jakubowski H, Goldman E. Synthesis of homocysteine thiolactone by methionyl-tRNA synthetase in cultured mammalian cells. FEBS Lett 1993; 317:593–8.Google Scholar

  • 15.

    Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. J Biol Chem 1997; 272:1935–42.Google Scholar

  • 16.

    Jakubowski H, Zhang L, Bardeguez A, Aviv A. Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ Res 2000; 87:45–51.Google Scholar

  • 17.

    Jakubowski H. Homocysteine-thiolactone and S-nitroso-homocysteine mediate incorporation of homocysteine into protein in humans. Clin Chem Lab Med 2003; 41:1462–6.Google Scholar

  • 18.

    Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med 1974; 291:537–41.Google Scholar

  • 19.

    Mercie P, Garnier O, Lascoste L, Renard M, Closse C, Durrieu F, et al. Homocysteine thiolactone induces caspase-independent vascular endothelial cell death with apoptotic features. Apoptosis 2000; 5:403–11.Google Scholar

  • 20.

    Ferretti G, Bacchetti T, Moroni C, Vignini A, Nanetti L, Curatola GT. Effects of homocysteinylation on low density lipoprotein peroxidation of human endothelial cells. J Cell Biochem 2004, 92:351–60.CrossrefGoogle Scholar

  • 21.

    Undas A, Perła J, Łaciński M, Trzeciak W, Kaźmierski R, Jakubowski H. Autoantibodies against N-homocysteinylated proteins in humans: implications for atherosclerosis. Stroke 2004; 35:1299–304.Google Scholar

  • 22.

    Perla J, Undas A, Twardowski T, Jakubowski H. Purification of antibodies against N-homocysteinylated proteins by affinity chromatography on Nω-homocysteinyl-aminohexyl-agarose. J Chromatogr B 2004; 807:257–61.Google Scholar

  • 23.

    Undas A, Jankowski M, Twardowska M, Padjas A, Jakubowski H, Szczeklik A. Antibodies to N-homocysteinylated albumin as a marker for early-onset coronary artery disease in men. Thromb Haemost 2005; 93:346–50.Google Scholar

  • 24.

    Ferretti G, Bacchetti T, Marotti E, Curatola GT. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity. Metabolism 2003, 52:146–51.CrossrefGoogle Scholar

  • 25.

    Binder CJ, Chang MK, Shaw PX, Miller YI, Hartvigsen K, Dewan A, et al. Innate and acquired immunity in atherosclerosis. Nat Med 2002; 8:1218–26.CrossrefGoogle Scholar

  • 26.

    Libby P. Inflammation in atherosclerosis. Nature 2002; 420:868–74.Google Scholar

About the article

Corresponding author: Hieronim Jakubowski, PhD Department of Microbiology and Molecular Genetics, UMDNJ-New Jersey Medical School, International Center for Public Health, 225 Warren Street, Newark, NJ 07101-1709, USA Phone: +1-973-972-4483, Fax: +1-973-972-8982,


Published Online: 2005-09-30

Published in Print: 2005-10-01


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2005.177.

Export Citation

©2005 by Walter de Gruyter Berlin New York. Copyright Clearance Center

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Zeynep G. Ozturk, Hakan Ekmekci, Ozlem B. Ekmekci, Pinar Atukeren, Ilknur Butun, Safa Gode, Kazim Besirli, Emine Kokoglu, and Huseyin Sonmez
Clinical and Applied Thrombosis/Hemostasis, 2010, Volume 16, Number 5, Page 554
[2]
Wei Hsi Chen, Hung Sheng Lin, Yi Fen Kao, Min Yu Lan, and Jia Shou Liu
Clinical and Applied Thrombosis/Hemostasis, 2007, Volume 13, Number 4, Page 398
[3]
Jarosław Zimny, Marta Sikora, Andrzej Guranowski, and Hieronim Jakubowski
Journal of Biological Chemistry, 2006, Volume 281, Number 32, Page 22485
[4]
Xin-Yu Mei, Xia-Di He, Lei Huang, Da-Shi Qi, Ji Nie, Yang Li, Wen Si, and Shi-Min Zhao
The FEBS Journal, 2016, Volume 283, Number 22, Page 4149
[5]
Kerina J. Denny, Christina F. Kelly, Vinod Kumar, Katey L. Witham, Robert M. Cabrera, Richard H. Finnell, Stephen M. Taylor, Angela Jeanes, and Trent M. Woodruff
Birth Defects Research Part A: Clinical and Molecular Teratology, 2016, Volume 106, Number 3, Page 201
[6]
Thekkuttuparambil Ananthanarayanan Ajith and Ranimenon
Clinica Chimica Acta, 2015, Volume 450, Page 316
[7]
R. Głowacki, K. Borowczyk, and E. Bald
Journal of Analytical Chemistry, 2014, Volume 69, Number 6, Page 583
[8]
Kerina J. Denny, Angela Jeanes, Kristin Fathe, Richard H. Finnell, Stephen M. Taylor, and Trent M. Woodruff
Birth Defects Research Part A: Clinical and Molecular Teratology, 2013, Volume 97, Number 9, Page 602
[9]
Vladimir Zivkovic, Vladimir Jakovljevic, Olga Pechanova, Ivan Srejovic, Jovana Joksimovic, Dragica Selakovic, Nevena Barudzic, and Dragan M. Djuric
BioMed Research International, 2013, Volume 2013, Page 1
[10]
A Nowakowska-Plaza, DP Potaczek, P Gluszko, and A Undas
Scandinavian Journal of Rheumatology, 2014, Volume 43, Number 1, Page 17
[11]
Hieronim Jakubowski
Phosphorus, Sulfur, and Silicon and the Related Elements, 2013, Volume 188, Number 4, Page 384
[12]
Shereem Mohamed Olama and Mohammed Mohamed Elarman
Rheumatology International, 2013, Volume 33, Number 6, Page 1487
[13]
Ulrike Kuebler, Michael Linnebank, Alexander Semmler, Birgit Stoffel-Wagner, Roberto La Marca, Ulrike Ehlert, and Petra H. Wirtz
Psychoneuroendocrinology, 2013, Volume 38, Number 8, Page 1381
[14]
Yulia Y. Stroylova, Jean-Marc Chobert, Vladimir I. Muronetz, Hieronim Jakubowski, and Thomas Haertlé
Archives of Biochemistry and Biophysics, 2012, Volume 526, Number 1, Page 29
[15]
Hieronim Jakubowski
Analytical Biochemistry, 2008, Volume 380, Number 2, Page 257
[16]
Joanna Kolodziejczyk-Czepas, Beata Talar, Pawel Nowak, Beata Olas, and Barbara Wachowicz
International Journal of Biological Macromolecules, 2012, Volume 50, Number 3, Page 754
[17]
Mohsen Kerkeni, Ahmed Letaief, Abdellatif Achour, Abdelhedi Miled, Francois Trivin, and Khira Maaroufi
Clinical Biochemistry, 2009, Volume 42, Number 9, Page 777
[18]
Gianna Ferretti, Tiziana Bacchetti, Simona Masciangelo, and Virginia Bicchiega
Chemistry and Physics of Lipids, 2010, Volume 163, Number 2, Page 228
[19]
P. Bogdanski, D. Pupek-Musialik, J. Dytfeld, M. Lacinski, A. Jablecka, and H. Jakubowski
Biomedicine & Pharmacotherapy, 2008, Volume 62, Number 6, Page 360
[20]
Joanna Perła-Kaján, Olaf Stanger, Michał Łuczak, Agnieszka Ziółkowska, Ludwik K. Malendowicz, Tomasz Twardowski, Šárka Lhotak, Richard C. Austin, and Hieronim Jakubowski
Biomedicine & Pharmacotherapy, 2008, Volume 62, Number 7, Page 473
[21]
Pietro Enea Lazzerini, Pier Leopoldo Capecchi, Enrico Selvi, Sauro Lorenzini, Stefania Bisogno, Mauro Galeazzi, and Franco Laghi Pasini
Autoimmunity Reviews, 2007, Volume 6, Number 7, Page 503
[22]
Beata Olas, Joanna Kołodziejczyk, Magdalena Kedzierska, Joanna Rywaniak, and Barbara Wachowicz
Thrombosis Research, 2009, Volume 124, Number 6, Page 689
[23]
Alexey S. Chubarov, Makhmut M. Shakirov, Igor V. Koptyug, Renad Z. Sagdeev, Dmitry G. Knorre, and Tatyana S. Godovikova
Bioorganic & Medicinal Chemistry Letters, 2011, Volume 21, Number 13, Page 4050
[24]
Rafał Głowacki, Edward Bald, and Hieronim Jakubowski
Amino Acids, 2011, Volume 41, Number 1, Page 187
[25]
Michał Zaąbczyk, Rafał Głowacki, Andrzej Machnik, Paweł Heród, Grzegorz Kazek, Hieronim Jakubowski, and Anetta Undas
Clinical Chemistry and Laboratory Medicine, 2011, Volume 49, Number 4
[26]
Beata Olas, Joanna Malinowska, and Joanna Rywaniak
Platelets, 2010, Volume 21, Number 7, Page 533
[27]
Hieronim Jakubowski
Clinical Chemical Laboratory Medicine, 2007, Volume 45, Number 12
[28]
Rafał Głowacki, Edward Bald, and Hieronim Jakubowski
Amino Acids, 2010, Volume 39, Number 5, Page 1563
[29]
Aysun Toker, Melek Kadı, A. Kadir Yıldırım, Hulya Aksoy, and Fatih Akçay
Cell Biochemistry and Function, 2009, Volume 27, Number 3, Page 176
[30]
N Angayarkanni, S Barathi, T Seethalakshmi, R Punitham, R Sivaramakrishna, G Suganeswari, and S Tarun
Eye, 2008, Volume 22, Number 7, Page 969
[31]
J. Perła-Kaján, T. Twardowski, and H. Jakubowski
Amino Acids, 2007, Volume 32, Number 4, Page 561

Comments (0)

Please log in or register to comment.
Log in